Association between polymorphisms in the human chemokine receptor genes CCR2 and CX3CR1 and rheumatoid arthritis

Tissue Antigens

Volumn 62, Issue 2, 2003, Pages 170-174

  Bayley, Jean Pierre ^a,c   Baggen, J M ^b   V D Pouw Kraan, T ^b   Crusius, J B A ^b   Huizinga, T W J ^a   Verweij, C L ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Case control study; CCR2; CX3CR1, rheumatoid arthritis; Polymorphisms

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR1;

AMINO ACID SUBSTITUTION; ARTICLE; CELL TRANSPORT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOOT RADIOGRAPHY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAND RADIOGRAPHY; HUMAN; INFANT; INFLAMMATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OUTPATIENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SCORING SYSTEM; SYNOVIUM; X RAY ANALYSIS;

ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, CHEMOKINE; VARIATION (GENETICS);

EID: 0041528264     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2003.00073.x     Document Type: Article

References (21)

1. Ruth JH, Rottman JB, Katschke KJJ et al. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 2001: 44: 2750-60.
2. Zapico I, Coto E, Rodriguez A et al. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 2000: 1: 288-91.
3. Gomez-Reino JJ, Pablos JL, Carreira PE et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum 1999: 42: 989-92.
4. Garred P, Madsen HO, Petersen J et al. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol 1998: 25: 1462-5.
5. Mack M, Bruhl H, Gruber R et al. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum 1999: 42: 981-8.
6. Struyf F, Thoelen I, Charlier N et al. Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium. Hum Hered 2000: 50: 304-7.
7. Szalai C, Csaszar A, Czinner A et al. Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr Res 1999: 46: 82-4.
8. Petrek M, Drabek J, Kolek V et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000: 162: 1000-3.
9. Hizawa N, Yamaguchi E, Furuya K et al. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 1999: 159: 2021-3.
10. Foussat A, Coulomb-L'Hermine A, Gosling J et al. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 2000: 30: 87-97.
11. Ruth JH, Volin MV, Haines GK III et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 2001: 44: 1568-81.
12. Faure S, Meyer L, Costagliola D et al. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 2000: 287: 2274-7.
13. MacGregor AJ, Snieder H, Rigby AS et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000: 43: 30-7.
14. Brinkman BM, Huizinga TW, Kurban SS et al. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 1997: 36: 516-21.
15. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988: 31: 315-24.
16. Drossaers-Bakker KW, de Buck M, van Zeben D. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999: 42: 1854-60.
17. Sharp JT. Radiographic evaluation of the course of articular disease. Clin Rheum Dis 1983: 9: 541-57.
18. Santiago B, Galindo M, Rivero M et al. The chemo-attraction of lymphocytes by rheumatoid arthritis - synovial fluid is not dependent on the chemokine receptor CCR5. Rheumatol Int 2002: 22: 107-11.
19. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997: 277: 959-65.
20. Ioannidis JP, Rosenberg PS, Goedert JJ et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-13′ A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 2001: 135: 782-95.
21. Moatti D, Faure S, Fumeron F et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 2001: 97: 1925-8.